Trials / Completed
CompletedNCT03439319
Restoration of Reaching and Grasping Function in Individuals With Spinal Cord Injury Using MyndMove® Neuromodulation Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- MyndTec Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A two-arm, parallel group, multicentre, single-blind, randomized controlled trial comparing electrical neuromodulation delivered by MyndMove® therapy to intensive upper-limb conventional therapy in the treatment of patients with moderate to severe motor impairment to their arms and hands from an incomplete, traumatic spinal cord injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MyndMove® | This FES therapy can be used as a short-term therapeutic intervention to help improve voluntary grasping function |
| OTHER | Conventional Therapy | Conventional training involves repetitive practice of upper extremity movements with manual assistance provided by a therapist as needed. |
Timeline
- Start date
- 2019-06-03
- Primary completion
- 2022-02-28
- Completion
- 2022-03-31
- First posted
- 2018-02-20
- Last updated
- 2022-07-18
Locations
4 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03439319. Inclusion in this directory is not an endorsement.